To Evaluate the Clinical Efficacy of Probiotic in Patients with DKD
To evaluate the efficacy of probiotics in the treatment of diabetic kidney disease, this study is designed to explore after consumption of probiotics lactobacillus reuteri ADR-1 and lactobacillus rhamnosus GM-020 composite strain powder sachets for 6 months, whether the improvement of blood sugar, kidney related indicators can further improve the course of diabetic kidney disease. The clinical trial predicted that probiotics can improve diabetic kidney disease by changing the intestinal flora by inhibiting harmful bacteria, reduction of systemic oxidative stress, balance carbohydrate and fat metabolism, further preventing the progress of diabetic kidney disease.
• Age between 25 and 80 years old
• Suffering from type 2 diabetes and stable medication for 3 months
• Detection of HbA1c before meals between 7% and 10%
• Stage 1-3a diabetic nephropathies (eGFR \> 45 mL/min)
• Microalbuminuria estimated between 30 to 300 mg/day